Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ADIL I DAUD

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1699706812
CMS profile
167563
Location
TAMPA, FL

General Payments · PY2018–2024

$222,433.03

  • Reported across 191 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$33,393.92

20 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $20,008.14 8
Regeneron Pharmaceuticals, Inc. $7,844.15 7
Celltrion, Inc. $2,700.00 1
PFIZER INC. $2,025.00 2
Iovance Biotherapeutics, Inc. $685.00 1
Regeneron Healthcare Solutions, Inc. $131.63 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $48,870.19 57
PY2019 $48,636.84 44
PY2020 $24,664.11 17
PY2021 $23,653.37 7
PY2022 $21,293.15 17
PY2023 $21,921.45 29
PY2024 $33,393.92 20

Payment records · PY2024 (20)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Celltrion, Inc. $2,700.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1110443936 CMS
Iovance Biotherapeutics, Inc. $685.00 10/10/2024 Consulting Fee Undisputed 01/23/2026 1147114384 CMS
Merck Sharp & Dohme LLC $9,157.80 04/17/2024 Travel and Lodging Undisputed 01/23/2026 1141810472 CMS
Merck Sharp & Dohme LLC $238.06 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1141810470 CMS
Merck Sharp & Dohme LLC $383.07 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1141810482 CMS
Merck Sharp & Dohme LLC $238.06 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1141810466 CMS
Merck Sharp & Dohme LLC $32.46 04/19/2024 Food and Beverage Undisputed 01/23/2026 1141810468 CMS
Merck Sharp & Dohme LLC $48.69 04/19/2024 Food and Beverage Undisputed 01/23/2026 1141902760 CMS
Merck Sharp & Dohme LLC $9,760.00 05/06/2024 Consulting Fee Undisputed 01/23/2026 1141693900 CMS
Merck Sharp & Dohme LLC $150.00 05/06/2024 Travel and Lodging Undisputed 01/23/2026 1141693902 CMS
PFIZER INC. $1,875.00 01/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1130943653 CMS
PFIZER INC. $150.00 06/02/2024 Food and Beverage Undisputed 01/23/2026 1131477557 CMS
Regeneron Healthcare Solutions, Inc. $131.63 06/20/2024 Food and Beverage Undisputed 01/23/2026 1114033440 CMS
Regeneron Pharmaceuticals, Inc. $359.65 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114397953 CMS
Regeneron Pharmaceuticals, Inc. $3,745.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114397955 CMS
Regeneron Pharmaceuticals, Inc. $1,662.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114397957 CMS
Regeneron Pharmaceuticals, Inc. $415.50 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114397959 CMS
Regeneron Pharmaceuticals, Inc. $415.50 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114397961 CMS
Regeneron Pharmaceuticals, Inc. $415.50 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114397963 CMS
Regeneron Pharmaceuticals, Inc. $831.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114397965 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.